Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -606 | 4,677 | 10,021 | 10,880 | -5,090 |
| Depreciation Amortization | 166 | 6,099 | 1,573 | 1,146 | 190 |
| Accounts payable and accrued liabilities | 15 | 874 | -54 | -66 | -45 |
| Other Working Capital | 169 | 800 | 234 | 206 | 317 |
| Other Operating Activity | 5 | -13,902 | -13,146 | -13,332 | 3,666 |
| Operating Cash Flow | $-251 | $-1,453 | $-1,372 | $-1,166 | $-963 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 200 | N/A | 500 | 475 | N/A |
| Debt Issued | N/A | 966 | 983 | 983 | 500 |
| Common Stock Issued | N/A | 159 | 159 | 99 | 52 |
| Other Financing Activity | 0 | 0 | -585 | -560 | -60 |
| Financing Cash Flow | $200 | $1,125 | $1,057 | $997 | $492 |
| Beginning Cash Position | 262 | 589 | 589 | 589 | 589 |
| End Cash Position | 210 | 262 | 274 | 420 | 118 |
| Net Cash Flow | $-51 | $-327 | $-315 | $-169 | $-471 |
| Free Cash Flow | |||||
| Operating Cash Flow | -251 | -1,453 | -1,372 | -1,166 | -963 |
| Free Cash Flow | -251 | -1,453 | -1,372 | -1,166 | -963 |